IQV vs WAT
IQVIA and Waters Corporation, both Healthcare
Waters Corporation is the larger company at $35B against $28B. On trailing earnings IQV is the cheaper of the two at a P/E of 32.5 against 103.3, a gap that is only a bargain if the two are growing at similar rates. Over the past year WAT returned +49% against +47% for IQV. Ryufin's sector-relative Smart Score puts IQV ahead, 9/10 against 3/10.
| Figure | IQV | WAT |
|---|---|---|
| Last close | $262 | $414 |
| Market cap | $28B | $35B |
| Trailing P/Elower is cheaper for the same earnings, not automatically better | 32.5 | 103.3 |
| 1-year return | +47% | +49% |
| 5-year return | +5.6% | +6.3% |
| Ryufin Smart Scoresector-relative, 1–10 | 9/10 | 3/10 |
Figures from SEC filings and end-of-day closes. Highlighting marks the higher or lower number, which is not the same as the better investment, a low P/E can be a warning and a high one can be deserved.
IQVIA
Revenue of $4.2B in Q1 2026, net income $274M. Its largest reported line is Research And Development Solutions, 56% of the disclosed total.
Waters Corporation
Revenue of $1.6B in Q2 2026, net income null. Its largest reported line is Consumables, 43% of the disclosed total.
Open these two in the interactive comparison to add more names, change the period or read the correlation.